Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultralife (ULBI) Cash from Investing Activities (2016 - 2025)

Ultralife (ULBI) has disclosed Cash from Investing Activities for 16 consecutive years, with -$886000.0 as the latest value for Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 98.18% year-over-year to -$886000.0; the TTM value through Dec 2025 reached -$3.9 million, up 92.25%, while the annual FY2025 figure was -$3.9 million, 92.25% up from the prior year.
  • Cash from Investing Activities hit -$886000.0 in Q4 2025 for Ultralife, up from -$991000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$360000.0 in Q2 2024 and bottomed at -$48.6 million in Q4 2024.
  • Average Cash from Investing Activities over 5 years is -$4.9 million, with a median of -$736000.0 recorded in 2021.
  • Year-over-year, Cash from Investing Activities crashed 4738.61% in 2024 and then surged 98.18% in 2025.
  • Ultralife's Cash from Investing Activities stood at -$24.0 million in 2021, then skyrocketed by 98.45% to -$371000.0 in 2022, then crashed by 170.89% to -$1.0 million in 2023, then plummeted by 4738.61% to -$48.6 million in 2024, then soared by 98.18% to -$886000.0 in 2025.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at -$886000.0, -$991000.0, and -$1.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.